Effect of Ayurvedic treatment in chronic simple rhinitis
- Conditions
- Health Condition 1: J310- Chronic rhinitis
- Registration Number
- CTRI/2020/12/029618
- Lead Sponsor
- Sane Guruji Arogya Kendra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 68
1) Patients fulfilling the diagnostic criteria of Peenasa(Chronic Simple Rhinitis).
2) Patients suffering from three or more the following symptoms for more than one months were selected for study.( Nasal obstruction, Nasal discharge, Headache , Swollen turbinateâ??s, Post-Nasal discharge )
3) A patients having age group 18 to 60 years.
4) Patient willing to participate in the study.
5) Patients were recruited irrespective of sex, religion, occupation.
1) Pregnant women and Children.
2) Patients with history of congenital disorder of Nose.
3) Patients suffering from gross deviation of nasal septum and associated with other nasal pathology like nasal polyp etc.
4) Patients with uncontrolled systemic diseases like Diabetes Mellitus and Hypertension.
5) Chronic simple Rhinitis associated with Hyperthyroidism, Exanthemas, Adenoidal Hyperplasia, Choanal Atresia and Nasal Tumors.
6) Patient having Angle-Closure Glaucoma and Pyloric Stenosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome will be evaluation of efficacy of Nidigdhikadi Kwatha in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: The drug will be given for 21 days.The efficacy will be assessed on the basis of VAS SCALE for symptoms before and after treatment. The patients will be assessed before and after treatment. Total duration of the study will 18 months.
- Secondary Outcome Measures
Name Time Method A comparison between efficacy <br/ ><br>of Nidigdhikadi Kwatha and Tab Levocetrizine 5mg <br/ ><br>in combination with Phenylephrine 10mg in <br/ ><br>Peenasa Vyadhi w.r.t Chronic Simple Rhinitis will be doneTimepoint: Total duration of study is 18 Months. Baseline assessment will be done of each patient before and after treatment. Each patient will be treated for 21days. Assessment will be done on VAS SCALE